Uncovering the molecular mechanisms behind immune system activation could help in future gene therapies

January 29, 2014
Pinpointing an immune-response trigger
During bacterial infection (purple discs), or cell transformations such as tumor growth, cells accumulate IPP antigens (light blue circles), which then bind to butyrophilin 3A1 (red). Together, they stimulate the T-cell receptors (TCR) of gamma delta T cells (right). Credit: A*STAR Singapore Immunology Network

The ability to recognize antigens from invading microbes and damaged host cells allows the human body to trigger powerful immune responses. A particular group of white cells, known as gamma delta T cells (γδ T cells), is activated during initial infection in response to the accumulation of an antigen called isopentenyl pyrophosphate (IPP). However, as IPP does not bind directly with γδ T-cell receptors, researchers assumed that another molecule was responsible for presenting IPP to γδ T cells.

Now, Gennaro De Libero and co-workers at the A*STAR Singapore Immunology Network and A*STAR Singapore Bioimaging Consortium—together with scientists from Switzerland, Australia and the United Kingdom—have shown that a protein called butyrophilin 3A1 (BTN3A1) activates human γδ T by binding with IPP. Their discovery could lead to targeted therapies for tumors and other diseases that require a heightened, rapid immune response.

"In our preliminary studies, we found that a γδ T-cell antigen-presenting molecule (APM) was distributed in many tissues and was different from all the other known APMs," explains De Libero. "We exploited a novel strategy to identify the gene encoding the APM."

In initial investigations into human γδ T cells, the team found that their data was complicated by high background readings from other white-cell activity. To minimize this interference, they generated transgenic mice capable of expressing specific human γδ T-cell receptor chains. Through careful screening, the researchers found that only certain human cells were able to present IPP and activate the γδ T cells.

"By pinpointing these cell types, we were able to use the mouse–human hybrid cells to map the human chromosome and find the locus in which the gene encoding the unknown APM was located," explains De Libero. "By applying molecular and cellular techniques, we then identified the molecule as BTN3A1."

Using mass spectroscopy, the researchers were able to visualize the formation of BTN3A1-antigen complexes. IPP antigens bind to a small cleft in BTN3A1 to form a stable complex, which in turn stimulates the γδ T-cell receptors (see image). When BTN3A1 is inhibited, fewer IPP antigens are presented to γδ T cells, weakening the immune response.

The team found that BTN3A1 is widely expressed in the body, particularly in tumor cells where host IPP is prevalent. BTN3A1 could therefore play a vital role in new gene therapies.

"BTN3A1 might be exploited to present stimulatory antigens to human γδ T cells," says De Libero. "This could be used to preferentially kill ."

Explore further: Novel mechanism discovered in first line of immune defence

More information: Vavassori, S., Kumar, A., Wan, G. S., Ramanjaneyulu, G. S., Cavallari, M. et al. Butyrophilin 3A1 binds phosphorylated antigens and stimulates human γδ T cells. Nature Immunology 14, 908–916 (2013). dx.doi.org/10.1038/ni.2665

Related Stories

Novel mechanism discovered in first line of immune defence

September 10, 2013
Scientists from A*STAR's Singapore Immunology Network (SIgN) have discovered a new defense mechanism that the immune system utilises to combat infections. The team's discovery of how a novel protein unexpectedly activates ...

Adoptive cell transfer: New technique could make cell-based immune therapies for cancer safer, more effective

December 16, 2012
A team led by Michel Sadelain, MD, PhD, Director of the Center for Cell Engineering at Memorial Sloan-Kettering Cancer Center, has shown for the first time the effectiveness of a new technique that could allow the development ...

Lipids produced within the thymus give immune cells the initial boost they need to fight off infection

September 12, 2012
Semi-invariant natural killer T (iNKT) cells wage war against infectious threats, attacking microbial cells and generating signals that enable other immune cells also to respond aggressively. iNKT cells initially undergo ...

Engineered T cells kill tumors but spare normal tissue in an animal model

April 7, 2013
The need to distinguish between normal cells and tumor cells is a feature that has been long sought for most types of cancer drugs. Tumor antigens, unique proteins on the surface of a tumor, are potential targets for a normal ...

Getting personal with hep B vaccines

December 19, 2013
Therapeutic vaccines that boost antiviral immunity provide an attractive alternative to drug therapy for people who are infected with the hepatitis B virus (HBV). Yet, the large amount of genetic diversity found in circulating ...

Technique for analyzing specific T-cell responses could pave way for more rationally designed vaccines

September 11, 2013
Among different populations, a vaccine can vary in efficacy against a specific pathogen. Unraveling the discrepancy requires tools to analyze the exact nature of responses by a specific type of immune cell: the T cell. Now, ...

Recommended for you

Australian researchers in peanut allergy breakthrough

August 17, 2017
Australian researchers have reported a major breakthrough in the relief of deadly peanut allergy with the discovery of a long-lasting treatment they say offers hope that a cure will soon be possible.

Genetic variants found to play key role in human immune system

August 16, 2017
It is widely recognized that people respond differently to infections. This can partially be explained by genetics, shows a new study published today in Nature Communications by an international collaboration of researchers ...

Study identifies a new way to prevent a deadly fungal infection spreading to the brain

August 16, 2017
Research led by the University of Birmingham has discovered a way to stop a deadly fungus from 'hijacking' the body's immune system and spreading to the brain.

Biophysics explains how immune cells kill bacteria

August 16, 2017
(Tokyo, August 16) A new data analysis technique, moving subtrajectory analysis, designed by researchers at Tokyo Institute of Technology, defines the dynamics and kinetics of key molecules in the immune response to an infection. ...

How a nutrient, glutamine, can control gene programs in cells

August 15, 2017
The 200 different types of cells in the body all start with the same DNA genome. To differentiate into families of bone cells, muscle cells, blood cells, neurons and the rest, differing gene programs have to be turned on ...

Scientists identify gene that controls immune response to chronic viral infections

August 15, 2017
For nearly 20 years, Tatyana Golovkina, PhD, a microbiologist, geneticist and immunologist at the University of Chicago, has been working on a particularly thorny problem: Why are some people and animals able to fend off ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.